Status:
UNKNOWN
Red Yeast Rice and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis
Lead Sponsor:
Chengdu PLA General Hospital
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
To evaluate the effect of red yeast rice on subclinical atherosclerosis in patients with rheumatoid arthritis
Eligibility Criteria
Inclusion
- patients with a definite diagnose of rheumatoid arthritis(RA) were included if they met the classification criteria for RA established by the American Rheumatism Association (ACR) and European League Against Rheumatism (EULAR) in 2010
- aged from 18 to 75 years
- without conflict to the written, informed consent signed prior to the enrollment
- no severe hepatic or renal disorders
- no known carotid artery stenosis
- no coagulation disorders
- no hypertension
Exclusion
- being in pregnancy, lactation period or under a pregnancy plan
- being allergic to the test drug
- not compatible for the trial medication
- without full legal capacity
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02257047
Start Date
October 1 2014
End Date
March 1 2019
Last Update
October 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Chengdu Military Area Command PLA
Chengdu, Sichuan, China, 610083